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Variable
Monitoring service
TotalMD AS
Hospitalizations,
No. (%)
289 (12.8) 3 (2.3) 292 (15.1)
Cost per
hospitalization
$15,125.00 $17,794.00
Cost per patient
treated
$1929.00 $407.00
Savings per patient
treated by AS
$1522.00
Annual savings/100
patients treated
by AS
$304,400.00
Total annual
savings/100
patients treated
by AS
$310,200.00
AS, Anticoagulation service; MD, medical doctor.
Conclusions: Management of long-term VKA therapy by an AS with
established protocols reduces anticoagulation morbidity, resulting in signif-
icant cost savings by reducing the number of ED visits and hospitalizations.
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From King’s College London.
Background: Current imaging modalities are unable to accurately
assess the degree of organization in venous thrombi. We used a mouse
model of thrombosis to optimize and validate a novel magnetic resonance
imaging (MRI) protocol for the quantification of organization during
venous thrombus resolution.
Methods: AMR T1 relaxation mapping sequence was used to image
venous thrombi in 30 male BALB/C mice. T1 relaxation times were
quantified after 7, 10, 14, 21, and 28 days, using MATLAB and OsiriX
analysis of ParRec and DICOM data sets. Thrombus was harvested and
processed for histology after imaging from groups of mice at each time
interval (n  3/group). Sections obtained from at least 10 defined
intervals throughout the thrombus were stained for markers of organi-
zation, including red cell and collagen content (martius/scarlet/blue
stain) and hemosiderin content (Perl stain). Three blinded observers
used image analysis to calculate the percentage area of thrombus con-
taining stain and correlated these with the T1 relaxation times of the
corresponding MR scan slices.
Results: The mean T1 relaxation time of the thrombus proportionally
increased with time (Fig 1). Stronger correlations were observed between
the mean T1 relaxation time of the thrombi and collagen (Fig 2) or
hemosiderin content (R2  0.72, P  .0001). The red cell content of
thrombi had a weaker but significant correlation with T1 times (R2 0.41;
P  .01).
Conclusions:MR T1 relaxation mapping can be used as a noninvasive
method for the longitudinal quantification of thrombus organization and
requires no contrast. This technique could be used to predict clinical
outcome after deep vein thrombosis, guide management, and assess the
efficacy of treatments in both pre-clinical and clinical settings.
The Controversy of Managing Calf Vein Thrombosis: A Systematic Review
E. M. Masuda,a F. Liquido,a and Q. He,b Honolulu, Hawaii
From Straub Clinic & Hospital,a and Pacific Health Research Institute.b
Background: The lack of evidence-based data regarding the optimal
treatment of calf deep vein thrombosis (C-DVT) has resulted in controversy
about whether all C-DVT should be treated with anticoagulation or observed
with duplex surveillance. The studies published have reported highly variable
statistics on pulmonary emboli rates associated with C-DVT and clot propaga-
tion to the popliteal vein or higher. As a result, this analysis was undertaken to
determine the incidence of these events associated with C-DVT.
Methods: We reviewed 1460 articles that were published from 1975 to
2009 using computerized database searches of PubMed, Cochrane Controlled
Trials Register, and extensive cross references. The quality of the reports were
reviewed by two investigators (E.M., F.L.), and articles underwent strict selec-
tion based on specific inclusion and exclusion criteria. Studies were required to
have clear definitions of C-DVT, including involvement of muscular (soleal,
gastrocnemius) or axial veins (peroneal, posterior tibial, peroneal), or both, but
not involving the popliteal vein, clearly defined inception cohort, design by
randomized controlled trial (RCT) or prospective trial, or serial surveillance by
duplex ultrasound scanning or radionuclide testing supplemented by venogra-
phy. Only English-language articles were reviewed.
Results: Of the 1460 citations reviewed, there were 14 relevant En-
glish-language papers that met the selection criteria: 3 RCTs and 11 pro-
spective observational cohort studies. No RCTs were designed to compare
anticoagulation vs observation with duplex scan surveillance. The three
RCTs had varied regimens of anticoagulation dosing and duration. Pulmo-
nary emboli (PE) during presentation were reported up to 33%, whereas PE
during surveillance in the pooled data analysis were 3.5%, including those
treated and untreated. Propagation to the popliteal vein or higher tended to
be greater in those groups not treated with anticoagulation vs those treated
with anticoagulation.
Conclusions: Compared with PE at presentation, the incidence of PE
during surveillance of C-DVT is low. The risk of propagation to the popliteal
vein or higher must be considered in determining optimal treatment.
Scientific evidence guiding treatment is lacking, and RCT’s comparing
anticoagulation against duplex ultrasound surveillance are needed to deter-
mine the best approach.
Validation of the Caprini Risk Assessment Model in Plastic and Recon-
Structive Surgery Patients
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Background: In contrast with other surgical subspecialties, the plastic
surgery literature demonstrates a paucity of research on the efficacy of
chemoprophylaxis in venous thromboembolism (VTE) prevention. As a
result, we created a consortium of three tertiary referral centers with dem-
onstrated expertise in plastic and reconstructive surgery to perform a pro-
spective cohort study with historic controls to examine the efficacy of
low-molecular-weight heparin prophylaxis for VTE prevention in plastic
surgery patients.
Methods: A midterm analysis of the study’s control group was con-
ducted to evaluate the incidence of VTE when chemoprophylaxis is not
provided and to validate the predictive ability of the Caprini Risk Assessment
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